首页/数据集/Disruption of Iron Homeostasis Sensitizes Pancreatic Cancer to Irreversible Electroporation (revised)

Disruption of Iron Homeostasis Sensitizes Pancreatic Cancer to Irreversible Electroporation (revised)

Name: Disruption of Iron Homeostasis Sensitizes Pancreatic Cancer to Irreversible Electroporation (revised)
Creator: Huazhong University of Science and Technology Tongji Medical Collenge
Published: 2025-09-02T18:26:04+08:00

integrated proteome resources2026-02-07 收录

胰腺癌治疗

不可逆电穿孔

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0013269000 数据链接链接失效反馈

官方服务：

资源简介：

Disruption of Iron Homeostasis Sensitizes Pancreatic Cancer to Irreversible Electroporation (revised)

应用场景：

提供机构：

Huazhong University of Science and Technology Tongji Medical Collenge

创建时间：

2025-09-02

胰腺癌治疗

临床试验分析

Table S1 Hazard Ratios with and without Inverse Probability Weights Table S2 Multivariate Analysis: Prognostic Factors for Overall Survival

Mendeley Data2024-06-25 更新100

Ultrasonic cavitation induces necrosis and impairs growth in three-dimensional models of pancreatic ductal adenocarcinoma

胰腺癌治疗

超声空化

Introduction: Pancreatic ductal adenocarcinoma (PDAC) is a rapidly increasing cause of mortality whose dismal prognosis is mainly due to overwhelming chemoresistance. New therapeutic approaches inclu

DataONE2020-06-24 更新50

Data_Sheet_1_Liver tissue remodeling following ablation with irreversible electroporation in a porcine model.PDF

不可逆电穿孔

组织再生

Irreversible electroporation (IRE) is a method of non-thermal focal tissue ablation characterized by irreversibly permeabilizing the cell membranes while preserving the extracellular matrix. This stud

NIAID Data Ecosystem20

Supplementary Material for: Long term survival in pancreatic adenocarcinoma with metachronous hepatic metastases using multimodality treatment including pegylated liposomal irinotecan and capecitabine: a case report

胰腺癌治疗

生存分析

Introduction Pegylated liposomal irinotecan (nal-IRI) in combination with fluorouracil (5-FU) and leucovorin (LV) has achieved a median overall survival of 6.1 months in patients with metastatic pancr

DataCite Commons2025-06-04 更新80

Table_4_S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study.docx

胰腺癌治疗

药物疗效

BackgroundIn our previous phase II study, nab-paclitaxel plus S-1 (NPS) showed encouraging objective response rate (ORR) as first-line treatment for advanced pancreatic adenocarcinoma (APAC). This stu

NIAID Data Ecosystem40

Disruption of Iron Homeostasis Sensitizes Pancreatic Cancer to Irreversible Electroporation (revised)

资源简介：

相关数据集